首页 | 本学科首页   官方微博 | 高级检索  
     

直肠癌术前新辅助放疗进展
引用本文:石芳,于金明. 直肠癌术前新辅助放疗进展[J]. 中华结直肠疾病电子杂志, 2016, 5(1): 2-5. DOI: 10.3877/cma.j.issn.2095-3224.2016.01.01
作者姓名:石芳  于金明
作者单位:1. 250117 济南,山东省肿瘤医院特需一科
摘    要:术前同步放化疗是局部进展期可切除直肠癌的标准治疗。取得了与术后同步放化疗相似的生存率,并进一步降低了局部复发率,同时提高了保肛率。通过术前同步放化疗达到病理完全缓解的患者有更好的预后。本文将介绍直肠癌术前放疗的进展。

关 键 词:直肠肿瘤  治疗  磁共振成像  病理学  
收稿时间:2016-01-01

The progress in research on neoadjuvant radiotherapy for rectal cancer
Fang Shi,Jinming Yu. The progress in research on neoadjuvant radiotherapy for rectal cancer[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2016, 5(1): 2-5. DOI: 10.3877/cma.j.issn.2095-3224.2016.01.01
Authors:Fang Shi  Jinming Yu
Affiliation:1. Department of Special Ward, Shandong Cancer Hospital, Jinan 250117, China
Abstract:Neoadjuvant chemoradiation therapy (CRT) has been established as the standard care for local advanced rectal cancer. This approach has reduced the risk of local recurrence, led to reliable tumor down-staging and more sphincter preserving. For all these reasons, it has similar survival compared with adjuvant chemoradiation. Patients who achieve pathological complete response (pCR) after CRT have better long-term outcomes.
Keywords:Rectal neoplasms  Therapy  Magnetic resonance imaging  Pathology  
点击此处可从《中华结直肠疾病电子杂志》浏览原始摘要信息
点击此处可从《中华结直肠疾病电子杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号